Clinical Trial Update: Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating aspirin versus placebo in patients with resected colorectal cancer carrying a PI3K mutation and high-risk stage II/III disease and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Colorectal Cancer | Phase 3 | Status: RECRUITING